Fibroblast growth factor 21 is elevated in metabolically unhealthy obesity and affects lipid deposition, adipogenesis, and adipokine secretion of human abdominal subcutaneous adipocytes

Objective: Serum concentrations of the hepatokine fibroblast growth factor (FGF) 21 are elevated in obesity, type-2 diabetes, and the metabolic syndrome. We asked whether FGF21 levels differ between subjects with metabolically healthy vs. unhealthy obesity (MHO vs. MUHO), opening the possibility tha...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Lucia Berti (Egilea), Martin Irmler (Egilea), Marty Zdichavsky (Egilea), Tobias Meile (Egilea), Anja Böhm (Egilea), Norbert Stefan (Egilea), Andreas Fritsche (Egilea), Johannes Beckers (Egilea), Alfred Königsrainer (Egilea), Hans-Ulrich Häring (Egilea), Martin Hrabě de Angelis (Egilea), Harald Staiger (Egilea)
Formatua: Liburua
Argitaratua: Elsevier, 2015-07-01T00:00:00Z.
Gaiak:
Sarrera elektronikoa:Connect to this object online.
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Internet

Connect to this object online.

3rd Floor Main Library

Aleari buruzko argibideak 3rd Floor Main Library
Sailkapena: A1234.567
Alea 1 Eskuragarri